Correction to Astra, Hutchison China Cancer Drug Article on Sunday
April 01 2019 - 11:36AM
Dow Jones News
Results from a phase 1 clinical trial titled Tatton yielded
positive results. "Positive Data From Astra, Hutchison China Cancer
Drug Trial," on March 31, misstated the name of the trial in the
first paragraph. It is called Tatton, not Patton.
(END) Dow Jones Newswires
April 01, 2019 11:21 ET (15:21 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
AstraZeneca (NYSE:AZN)
Historical Stock Chart
From Mar 2024 to Apr 2024
AstraZeneca (NYSE:AZN)
Historical Stock Chart
From Apr 2023 to Apr 2024